Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRNA
1651
DELISTED
Verona Pharma
VRNA
| $6.95M | ﹤0.01% |
109,501
+104,188
| +1,961% | +$6.23M |
|
1652
Allison Transmission
ALSN
$10.3B
| $6.95M | ﹤0.01% |
72,631
+10,679
| +17% | +$1.13M |
|
1653
Novanta
NOVT
$6.34B
| $6.95M | ﹤0.01% |
54,334
-28,979
| -35% | -$4.17M |
|
1654
Zeta Global
ZETA
$7.32B
| $6.92M | ﹤0.01% |
510,460
+40,847
| +9% | +$730K |
|
1655
Coca-Cola Consolidated
COKE
$12.1B
| $6.92M | ﹤0.01% |
51,260
-9,880
| -16% | -$1.33M |
|
|
PRO
1656
DELISTED
PROS Holdings
PRO
| $6.92M | ﹤0.01% |
363,525
+97,803
| +37% | +$2.28M |
|
1657
Coeur Mining
CDE
$19.1B
| $6.91M | ﹤0.01% |
1,167,819
+192,054
| +20% | +$1.18M |
|
|
TXNM
1658
TXNM Energy Inc
TXNM
$5.91B
| $6.89M | ﹤0.01% |
128,830
-73,051
| -36% | -$3.67M |
|
1659
Xerox
XRX
$423M
| $6.89M | ﹤0.01% |
1,426,022
+1,161,037
| +438% | +$8.71M |
|
1660
TD Synnex
SNX
$20.3B
| $6.87M | ﹤0.01% |
66,037
-31,580
| -32% | -$4.22M |
|
1661
10x Genomics
TXG
$7.62B
| $6.86M | ﹤0.01% |
785,830
-5,127
| -0.6% | -$64.6K |
|
1662
Lincoln National
LNC
$8.51B
| $6.85M | ﹤0.01% |
190,850
+73,507
| +63% | +$2.61M |
|
1663
Lithia Motors
LAD
$8.32B
| $6.85M | ﹤0.01% |
23,323
-68,505
| -75% | -$23.3M |
|
1664
Webster Financial
WBS
$12.8B
| $6.84M | ﹤0.01% |
132,765
-246,901
| -65% | -$13.7M |
|
1665
Workiva
WK
$3.76B
| $6.84M | ﹤0.01% |
90,149
-25,826
| -22% | -$2.44M |
|
|
EQC
1666
DELISTED
Equity Commonwealth
EQC
| $6.84M | ﹤0.01% |
4,247,915
+514
| +0% | +$865 |
|
1667
SPS Commerce
SPSC
$2.7B
| $6.83M | ﹤0.01% |
51,494
-17,698
| -26% | -$2.78M |
|
1668
Under Armour
UAA
$2.29B
| $6.83M | ﹤0.01% |
1,093,530
+699,154
| +177% | +$5.21M |
|
1669
iShares US Aerospace & Defense ETF
ITA
$15B
| $6.83M | ﹤0.01% |
44,600
+36,998
| +487% | +$5.65M |
|
|
NUVL
1670
DELISTED
Nuvalent
NUVL
| $6.81M | ﹤0.01% |
96,037
-2,084
| -2% | -$163K |
|
1671
CALL
Marvell Technology
MRVL
$191B
| $6.8M | ﹤0.01% |
110,500
-318,100
| -74% | -$30.9M |
|
|
SLSR
1672
Solaris Resources
SLSR
$1.36B
| $6.78M | ﹤0.01% |
1,999,200
| – | – |
|
1673
Agree Realty
ADC
$9.13B
| $6.78M | ﹤0.01% |
87,785
-35,943
| -29% | -$2.63M |
|
1674
e.l.f. Beauty
ELF
$5.61B
| $6.77M | ﹤0.01% |
107,881
-53,978
| -33% | -$4.7M |
|
|
SLNO
1675
CALL
DELISTED
Soleno Therapeutics
SLNO
| $6.77M | ﹤0.01% |
+94,700
| New | +$4.61M |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.